NICE guidance on inclisiran should be reconsidered
- PMID: 34642203
- DOI: 10.1136/bmj.n2462
NICE guidance on inclisiran should be reconsidered
Conflict of interest statement
Competing interests: The BMJ has judged that there are no disqualifying financial ties to commercial companies. The authors declare no other interests. Provenance and peer review: Commissioned; not externally peer reviewed.
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources